Floatz logo

Cilostazol

Cerebral Infarction

Asan Medical CenterUNKNOWNPhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
77/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Cerebral Infarction cohort.

Asset / SponsorPhaseRating
Aspirin
Sclnow Biotechnology Co., Ltd.
Phase 4BBB
Sovateltide
Pharmazz, Inc.
Phase 4BBB
CLOPIDOGREL
The Second Hospital of Anhui Medical University
Phase 4BBB
Human Urinary Kallidinogenase
Huisheng Chen
Phase 4BB
Tenecteplase
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3BB

View all 49 →

Same molecule, other indications

Cilostazol is also rated in:

transient ischemic attackActive
BBB
Indicative · Phase 4
75 / 100
View asset →
ischemic strokeActive
BBB
Indicative · Phase 4
74 / 100
View asset →
stroke disorderActive
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →